Oral delivery of exenatide via microspheres prepared by cross-linking of alginate and hyaluronate

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhang, Baojie ^a   He, Dongyang ^a   Fan, Yu ^a   Liu, Nan ^a   Chen, Yijun ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; EXENDIN 4; GLUCOSE; HYALURONIC ACID; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; CHROMATOGRAPHY, GAS; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; GLUTARAL; HEXURONIC ACIDS; HYALURONIC ACID; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MOLECULAR WEIGHT; PEPTIDES; SURFACE-ACTIVE AGENTS; VENOMS;

EID: 84908181114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086064     Document Type: Article

References (29)

1. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, et al. (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of Insulin-secreting b-cells. J Biol Chem 268:19650-19656.
2. Fehmann HC, Göke R, Göke B (1992) Glucogan-like peptide-1(7-37)/(7-36) amide is a new incretin. Mol Cell Endocrinol 85: C39-44.
3. Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827. (Pubitemid 34000786)
4. Davidson MB, Bate G, Kirkpatrick P (2005) Exenatide. Nat Rev Drug Discov 4: 713-714.
5. Gedulin BR, Smith PA, Jodka CM, Chen K, Bhavsar S, et al. (2008) Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration. Int J Pharm 356: 231-238.
6. Fasano A (1998) Innovative strategies for the oral delivery of drugs and peptides. Trends Biotechnol 16: 152-157.
7. Hamman JH, Enslin GM, Kotzé AF (2005) Oral delivery of peptide drugs barriers and developments. Bio Drugs 19: 165-177. (Pubitemid 40994232)
8. Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliver Rev 64: 557-570.
9. Sung HW, Sonaje K, Liao ZX, Hsu LW, Chuang EY (2012) pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications. Acc Chem Res 45: 619-629.
10. Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11: 905-910. (Pubitemid 44403178)
11. Jin CH, Chae SY, Son S, Kim TH, Um KA, et al. (2009) A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice. J Contrl Release 133: 172-177.
12. Gong N, Ma AN, Zhang LJ, Luo XS, Zhang YH, et al. (2011) Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. Brit J Pharmacol 163: 399-412.
13. Nguyen HO, Wey SP, Juang JH, Sonaje K, Ho YC, et al. (2012) The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vechicle and effects on subsequent insulin secretion in vivo. Biomaterials 32: 2673-2682.
14. Liew CV, Chan LW, Ching AL, Heng PWS (2006) Evaluation of sodium alginate as drug release modifer in matrix tablets. Int J Pharm 309: 25-37. (Pubitemid 43129461)
15. Esposito E, Menegatti E, Cortesi R (2005) Hyaluronan-based microspheres as tools for drug delivery: a comparative study. Int J Pharm 288: 35-49. (Pubitemid 39656453)
16. Appel EA, Loh XJ, Jones ST, Dreiss CA, Scherman OA (2012) Sustained release of proteins from high water content supramolecular polymer hydrogels. Biomaterials 33: 4646-4652.
17. Fundueanu G, Nastruzzi C, Carpov A, Desbrieres J, Rinaudo M (1999) Physicochemical characterization of Ca-alginate microparticles produced with different methods. Biomaterials 20: 1427-1435. (Pubitemid 29326814)
18. Fundueanu G, Esposito E, Mihai D, Carpov A, Desbrieres J, et al. (1998) Preparation and characterization of Ca-alginate microspheres by a new emulsification method. Int J Pharm 170: 11-21. (Pubitemid 28473242)
19. Gombotz WR, Wee SF (1998) Protein release from alginate matrices. Adv Drug Deliver Rev 31: 267-285. (Pubitemid 28191869)
20. Li M, Rouaud O, Poncelet D (2008) Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm 363: 26-39.
21. Kulkarni AR, Soppimath KS, Aminabhavi TM, Dave AM, Mehat MH (2000) Glutaraldehyde crosslinked sodium alginate beads containing liquid pesticide for soil application. J Control Release 63: 97-105. (Pubitemid 30046945)
22. Yeom CK, Lee KH (1998) Characterization of sodium alginate membrane crosslinked with glutaraldehyde in pervaporation separation. J Appl Polym Sci 67: 209-219. (Pubitemid 128586221)
23. Yun YH, Goetz DJ, Yellen P, Chen W (2004) Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25: 147-57. (Pubitemid 37324408)
24. Norbäck D (1998) Skin and respiratory symptomicrospheres from exposure to alkaline glutaraldehyde in medical services. Scand J Work Environ Health 14: 366-371.
25. Zeiger E, Gollapudi B, Spencer P (2005) Genetic toxcity and carcinogenicity studies of glutaraldehyde-a review. Mutat Res 589: 136-51. (Pubitemid 40431692)
26. Maya DP, Havazelet BP (2010) A quantitative analysis of alginate swelling. Carbohyd Polym 79: 1020-10207.
27. Bajpai SK, Sharma S (2004) Investigation of swelling/degradation behavior of alginate beads crosslinked with Ca2+and Ba2+ ions. React Funct Polym 59:129-140.
28. Colinet I, Dulong V, Mocanu G, Piction L, Cerf DL (2009) New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug. Eur J Pharm Biopharm 73:345-350.
29. Kim H, Park H, Lee J, Kim TH, Lee ES, et al. (2011) Highly porous large poly(lactic-co-glycolic acid) microspheres absorbed with palmity-acylated exendin-4 as a long-acting inhalation system for treating diabetes. Biomaterials 32: 1685-1693.